Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression.

MLA

Kadivar, Ali, et al. “Antiproliferative Effects of Imatinib Mesylate on ZR‑75‑1 and MDA‑MB‑231 Cell Lines via PDGFR‑β, PDGF‑BB, C‑Kit and SCF Expression.” International Journal of Molecular Medicine, vol. 42, no. 1, July 2018, pp. 414–24. EBSCOhost, https://doi.org/10.3892/ijmm.2018.3590.

APA

Kadivar, A., Ibrahim Noordin, M., Aditya, A., Kamalidehghan, B., Davoudi, E. T., Sedghi, R., & Akbari Javar, H. (2018). Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression. International Journal of Molecular Medicine, 42(1), 414–424. https://doi.org/10.3892/ijmm.2018.3590

Chicago

Kadivar, Ali, Mohamed Ibrahim Noordin, Arya Aditya, Behnam Kamalidehghan, Ehsan Taghizadeh Davoudi, Reihaneh Sedghi, and Hamid Akbari Javar. 2018. “Antiproliferative Effects of Imatinib Mesylate on ZR‑75‑1 and MDA‑MB‑231 Cell Lines via PDGFR‑β, PDGF‑BB, C‑Kit and SCF Expression.” International Journal of Molecular Medicine 42 (1): 414–24. doi:10.3892/ijmm.2018.3590.